Image Navigation to Launch Newest Image Guided Implantology Technology at the European Academy of Osseointegration Congress in Geneva

Dual surgical navigation and robotic system - without the robot - for dental implantology to be exhibited September 29-October 1

Image Navigation Ltd., a pioneer in surgical navigation systems, will launch their second generation Image Guided Implantology (IGI) system during the EAO Congress in Geneva next week, the company announced today.

The IGI system brings the precision of navigation and the safety of robotic tools to the field of dental implantology.  Its new transformative robotic Auto-stop feature stops the drill when it is outside the planned trajectory or location, thereby providing robotic surgery without the robot.  The foundation of Auto-stop is Image Navigation’s proprietary high accuracy, no-observable-lag tracking.

The Image Navigation proprietary patient-to-system connector enables a smooth and efficient chairside workflow without compromising its sub-mm pinpoint accuracy.  This allows the surgeon to focus on the patient – rather than constantly monitoring the connector for movement or rotation. The system enables both same day scan, plan and surgery, as well as surgery at a date subsequent to the CT scan, without any diminution of accuracy.

Lawrence Obstfeld, CEO of Image Navigation, said, “Our IGI 2.0 is a Waze for dental implantology, providing the highest accuracy in implant surgery together with the safety of robotics – without a large and expensive robot in the surgical field.  The surgeon navigates in real-time, according to the pre-surgical plan.  The auto-stop will disable the drill if it is not following the on-screen indicators displayed on the screen.  This new IGI 2.0 will usher in an exciting era of navigated and robotic dentistry.”

IGI extends the use of 3D dental CT scans from diagnosis and planning to the actual surgical procedure. The pre-op CT image is utilized as a detailed on-screen map, providing the surgeon with precise real-time visualization of the direction, position and depth of the drill tip. The current installed base of 120,000 Dental CT scanners worldwide represents about $5B in capital investment.

IGI version 2.0 is anticipated to reach the European market in H1 2023.

Image Navigation Ltd. will be exhibiting the new IGI 2.0 at the European Academy of Osseointegration Congress, at Palexpo Geneva, Switzerland, September 29 – October 1, Booth H31.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.